[go: up one dir, main page]

CN113481173A - Proximal biotin ligase and application thereof - Google Patents

Proximal biotin ligase and application thereof Download PDF

Info

Publication number
CN113481173A
CN113481173A CN202110545864.1A CN202110545864A CN113481173A CN 113481173 A CN113481173 A CN 113481173A CN 202110545864 A CN202110545864 A CN 202110545864A CN 113481173 A CN113481173 A CN 113481173A
Authority
CN
China
Prior art keywords
amino acid
biotin ligase
adjacent
lysine
turboid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110545864.1A
Other languages
Chinese (zh)
Other versions
CN113481173B (en
Inventor
李栋
王新禹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Biophysics of CAS
Original Assignee
Institute of Biophysics of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Biophysics of CAS filed Critical Institute of Biophysics of CAS
Priority to CN202110545864.1A priority Critical patent/CN113481173B/en
Publication of CN113481173A publication Critical patent/CN113481173A/en
Application granted granted Critical
Publication of CN113481173B publication Critical patent/CN113481173B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93Ligases (6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y603/00Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/04Other carbon-nitrogen ligases (6.3.4)
    • C12Y603/04015Biotin-[acetyl-CoA-carboxylase] ligase (6.3.4.15)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/33Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using ultraviolet light
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/62Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

本发明涉及基因工程,进一步的说是基因工程改造的邻近生物素连接酶,具体的说一种用邻近生物素连接酶进行蛋白质邻近标记及其应用。邻近生物素连接酶为生物素连接酶中位于ATP或者生物素结合口袋的催化中心位点附近定点插入非天然氨基酸。所得邻近生物素连接酶在未经过特定波长紫外照射或者未与特定化合物孵育时,抑制其邻近生物素连接酶的酶活性。而后对所得邻近生物素连接酶进行特定紫外波长照射或者加入特定化合物,将非天然氨基酸转化为天然氨基酸,恢复其酶活性。本发明邻近生物素连接酶可以消除以往生物素连接酶的非特异性背景,极大提高鉴定特定细胞器内蛋白质组的特异性。

Figure 202110545864

The present invention relates to genetic engineering, in particular to a genetically engineered adjacent biotin ligase, in particular to a protein adjacent labeling using the adjacent biotin ligase and its application. The adjacent biotin ligase is the site-directed insertion of an unnatural amino acid near the catalytic center site of the ATP or biotin binding pocket in the biotin ligase. The obtained adjacent biotin ligase can inhibit the enzymatic activity of its adjacent biotin ligase when it is not irradiated with a specific wavelength of ultraviolet light or incubated with a specific compound. Then, the obtained adjacent biotin ligase is irradiated with a specific ultraviolet wavelength or added with a specific compound to convert the unnatural amino acid into a natural amino acid and restore its enzymatic activity. The adjacent biotin ligase of the present invention can eliminate the non-specific background of the previous biotin ligase, and greatly improve the specificity of identifying the proteome in a specific organelle.

Figure 202110545864

Description

Proximal biotin ligase and application thereof
Technical Field
The invention relates to gene engineering, in particular to a proximity biotin ligase which is transformed by the gene engineering, and specifically relates to a protein proximity marker by using the proximity biotin ligase and application thereof.
Background
Proximity labeling has become an alternative to immunoprecipitation and traditional biochemical separations and, through use in conjunction with proteomics, has been widely used for macromolecular complex component identification, intracellular protein species analysis, and the construction of protein interaction networks. The strategy of proximity labeling technology is generally to express the protein of interest in fusion with a proximity-labeled enzyme, thereby targeting the protein of interest to a specific location within the cell. The proximity-labeled enzyme can catalyze biotinylation covalent link modification of a protein adjacent to the spatial position of the target protein by adding a small molecule substrate such as biotin, and the biotinylation modified protein can be enriched by using streptavidin-coupled beads and further identified by using mass spectrometry.
Currently, researchers have successfully developed the following two broad classes of enzymes for proximity tagging: (1) one type is the proximity-labeled mutant of Escherichia coli biotin ligase BirA, which mainly includes BirA-R118G (hereinafter this protein is referred to as BioID) [1,2] and TurboID [3 ]; (2) another class is soybean ascorbate peroxidase mutants, which mainly include APEX2[4 ].
The APEX2 has the advantage of high labeling speed of adjacent proteins and can be completed within about 1 minute, however, the biotin labeling of the adjacent proteins by the APEX2 needs to add hydrogen peroxide (H) into the culture medium2O2) This is toxic to live cell markers and is also difficult to apply to living tissue.
BioID has the advantages of using biotin as a substrate and having no cytotoxicity, and more than 100 reports about application of BioID exist at present. However, the major drawback of BioID is that it takes at least 18 hours for the biotin-labeled adjacent proteins to accumulate enough protein for mass spectrometric identification. TurboID is similar to BioID and is derived from mutation of biotin ligase of Escherichia coli, and the TurboID takes biotin as a substrate, and can shorten the labeling time to 10 min. TurboID has therefore found widespread use in mammalian cells and model organisms [5,6 ].
However, biotin is an essential substance for the growth of most mammalian cells, the gradual accumulation process of expression of TurboID and BioID in cells generally requires about 12 hours, and the gradual accumulation of TurboID and BioID can utilize biotin in cell culture media to generate higher background markers for adjacent proteins, thereby influencing the specificity of mass spectrum identification.
Unlike the classical codon, the amber codon UAG (TAG) can be used as a codon encoding pyrrolysine (lysine derivative), [ 2] in Methanococcus pasteurianus and Methanococcus jannaschii, respectively7]And a sense codon of tyrosine [ alpha ], [ alpha ] and [ alpha ], [ alpha ] and [ alpha ] a8]And not a stop codon. Orthogonal to mammals can be obtained by genetic engineering
Figure BDA0003073475050000011
And pyrrolidinyl-tRNA synthetase, whereby a derivative of lysine or a derivative of tyrosine is site-specifically inserted into the protein of interest in a mammalian cell.
If the adjacent biotin ligase TurboID can be made inactive in the process of accumulating expression and the activity of the biotin ligase can be recovered under the condition of receiving physical or chemical stimulation, the labeling background can be effectively reduced, the accuracy and specificity of the adjacent labeling can be improved, and the time and space resolution of the TurboID can be retained.
Disclosure of Invention
The invention aims to provide a protein proximity marker by using a light-controlled proximity biotin ligase and application thereof.
In order to achieve the purpose, the invention adopts the technical scheme that:
a proximal biotin ligase which is a site-specific insertion of an unnatural amino acid near the catalytic central site of the ATP or biotin-binding pocket of biotin ligase.
The obtained adjacent biotin ligase can inhibit the enzyme activity of the adjacent biotin ligase when the adjacent biotin ligase is not irradiated by specific wavelength ultraviolet or incubated with a specific type of compound. Then 365nm irradiation is carried out on the adjacent biotin ligase or the adjacent biotin ligase is incubated with a specific compound, the unnatural amino acid is converted into the natural amino acid, and the enzymatic activity of the natural amino acid is recovered.
The adjacent biotin ligase is obtained by mutating one or more sites of 183 th lysine, 132 th tyrosine and 172 th lysine in an amino acid sequence of a mutant of biotin ligase BirA derived from escherichia coli into unnatural amino acid, so that the enzyme activity of the adjacent biotin ligase is inhibited.
The adjacent biotin ligase is one or more of 183 th lysine, 132 th tyrosine and 172 th lysine in an amino acid sequence of biotin ligase TurboID, and is mutated into an unnatural amino acid; wherein the unnatural amino acid is an unnatural amino acid MNPY-lysine or an unnatural amino acid ONB-lysine.
The adjacent biotin ligase is characterized in that the 183 th lysine in the amino acid sequence shown in SEQ ID NO. 1 is mutated into an unnatural amino acid MNPY-lysine or an unnatural amino acid ONB-lysine, namely the amino acid sequence shown in SEQ ID NO. 4 and the amino acid sequence shown in SEQ ID NO. 5;
or the 132 th tyrosine in the amino acid sequence shown in SEQ ID NO. 1 is mutated into the unnatural amino acid ONB-tyrosine, namely the amino acid sequence shown in SEQ ID NO. 7.
Or the 172 th lysine in the amino acid sequence shown in SEQ ID NO. 1 is mutated into the unnatural amino acid MNPY-lysine or the unnatural amino acid ONB-lysine, namely the amino acid sequence shown in SEQ ID NO. 9 and the amino acid sequence shown in SEQ ID NO. 10.
A method for constructing adjacent biotin ligase by using two adjacent ATP of biotin ligase TurboID or near catalytic central sites of biotin binding pocket
Figure BDA0003073475050000021
And carrying out site-directed unnatural amino acid insertion with pyrrolidinyl-tRNA synthetase to obtain the adjacent biotin ligase.
The amino acid sequence of the biotin ligase TurboID is shown as SEQ ID NO. 1; the unnatural amino acid is an unnatural amino acid MNPY-lysine or an unnatural amino acid ONB-lysine or ONB-tyrosine.
Use of a proximal biotin ligase in mass spectrometry identification.
The adjacent biotin ligase is used for performing biotin labeling on adjacent protein under the condition of ultraviolet illumination with specific wavelength in mass spectrum identification.
A method for carrying out mass spectrometry identification by biotinylation labeling by using adjacent biotin ligase comprises the steps of utilizing the adjacent biotin ligase to be fused and expressed with target protein, locating the target protein to a specific organelle, then irradiating at 365nm to enable the adjacent biotin ligase to recover enzyme activity, further carrying out biotin labeling on the adjacent protein of the target protein, enriching the protein labeled by biotin by virtue of Streptavidin coupled magnetic beads, and carrying out mass spectrometry identification.
The invention has the advantages that:
the light-operated adjacent biotin ligase designed by the invention can completely inactivate the adjacent biotin ligase by mutating amino acid near the active center of the existing adjacent biotin ligase into unnatural amino acid, thereby eliminating the background generated in the accumulation expression process and greatly improving the accuracy and specificity of mass spectrum identification.
Drawings
FIG. 1 is a schematic diagram showing a comparison between a conventional biotin proximity ligase (A) and a light-controlled biotin proximity ligase (B) in accordance with the present invention.
FIG. 2 is a graph of biotinylated immunoblot results of total protein samples obtained under different treatment conditions and total protein detected using Streptavidin-HRP.
FIG. 3 shows the identification of proteins in mitochondrial matrix by using optically controlled biotin ligase PC-mito-TurboID-183-MNPYK obtained in the present invention; wherein (A) SILAC identifies the protein in the mitochondrial matrix, (B) compares the light-controlled proximity biotin ligase PC-mito-TurboID-183-MNPYK (upper half) with the published proximity biotin ligase mito-TurboID (lower half) to identify the number and specificity of the protein in the mitochondrial matrix.
Detailed Description
The following examples are presented to further illustrate embodiments of the present invention, and it should be understood that the embodiments described herein are for purposes of illustration and explanation only and are not intended to limit the invention.
The present invention relates to genetically engineered vicinal biotin ligases. The light-operated adjacent biotin ligase replaces lysine or tyrosine at a specific site with corresponding unnatural amino acids such as lysine or tyrosine derivatives, and the fixed-point insertion of the unnatural amino acids can eliminate the enzyme activity of the adjacent biotin ligase; under the ultraviolet irradiation of specific wavelength, the light-operated non-natural amino acid such as lysine or tyrosine derivative at specific site in the adjacent biotin ligase is converted into lysine or tyrosine, and then the activity of the adjacent biotin ligase is recovered, so that the biotinylation reaction of the adjacent protein is specifically carried out. The light-controlled adjacent biotin ligase can eliminate the non-specific background of the previous biotin ligase, and greatly improve the specificity of identifying proteome in a specific organelle.
The sequence and chemical structural formula of the invention are as follows:
the protein adjacent to biotin ligase TurboID is a mutant of biotin ligase BirA derived from Escherichia coli, and its sequence and DNA sequence are derived from the literature [3], specifically,
1: TurboID the protein sequence of SEQ ID NO:
KDNTVPLKLIALLANGEFHSGEQLGETLGMSRAAINKHIQTLRDWGVDVFTVPGKGYSLPEPIPLLNAKQILGQLDGGSVAVLPVVDSTNQYLLDRIGELKSGDACIAEYQQAGRGSRGRKWFSPFGANLYLSMFWRLKRGPAAIGLGPVIGIVMAEALRKLGADKVRVKWPNDLYLQDRKLAGILVELAGITGDAAQIVIGAGINVAMRRVEESVVNQGWITLQEAGINLDRNTLAATLIRELRAALELFEQEGLAPYLPRWEKLDNFINRPVKLIIGDKEIFGISRGIDKQGALLLEQDGVIKPWMGGEISLRSAEK
2 DNA sequence of TurboID SEQ ID NO:
aaagacaatactgtgcctctgaagctgatcgctctcctggctaatggcgagttccatagtggcgaacagctgggagaaaccctgggcatgtccagggccgctatcaacaagcacattcagactctgcgcgactggggcgtggacgtgttcaccgtgcccggaaagggctactctctgcccgagcctatcccgctgctgaacgctaaacagattctgggacagctggacggcgggagcgtggcagtcctgcctgtggtcgactccaccaatcagtacctgctggatcgaatcggcgagctgaagagtggggatgcttgcattgcagaatatcagcaggcagggagaggaagcagagggaggaaatggttctctccttttggagctaacctgtacctgagtatgttttggcgcctgaagcggggaccagcagcaatcggcctgggcccggtcatcggaattgtcatggcagaagcgctgcgaaagctgggagcagacaaggtgcgagtcaaatggcccaatgacctgtatctgcaggatagaaagctggcaggcatcctggtggagctggccggaataacaggcgatgctgcacagatcgtcattggcgccgggattaacgtggctatgaggcgcgtggaggaaagcgtggtcaatcagggctggatcacactgcaggaagcagggattaacctggacaggaatactctggccgctacgctgatccgagagctgcgggcagccctggaactgttcgagcaggaaggcctggctccatatctgccacggtgggagaagctggataacttcatcaatagacccgtgaagctgatcattggggacaaagagattttcgggattagccgggggattgataaacagggagccctgctgctggaacaggacggagttatcaaaccctggatgggcggagaaatcagtctgcggtctgccgaaaag
chemical structure of MNPY-lysine (MNPYK) and method for inserting unnatural amino acid MNPY-lysine (MNPYK)
Figure BDA0003073475050000041
And MNPYK-tRNA synthetase DNA sequence please refer to [9]。
Chemical structure of ONB-lysine (ONBK) and insertion of unnatural amino acid ONB-lysine (ONBK)
Figure BDA0003073475050000042
And the DNA sequence of ONBK-tRNA synthetase [10]。
Chemical structure of ONB-tyrosine (ONBY) and used for inserting unnatural amino acid ONB-tyrosine (ONBY)
Figure BDA0003073475050000043
And the DNA sequence of ONBY-tRNA synthetase [11]。
Example 1
Technical scheme for expressing and activating light-operated biotin ligase PC-TurboID-183-MNPYK
1) Through site-directed mutagenesis, the codon of 183 th lysine in TurboID is mutated into amber codon TAG, and TurboID-183 plasmid shown as SEQ ID NO. 3 is obtained; the method specifically comprises the following steps:
using NEB corporation
Figure BDA0003073475050000044
Site-Directed Mutagenesis Kit and NEB online design PCR primer NEBBaseChanger, and the following two primers are designed:
a forward primer: 5'-GCAGGATAGAtAGCTGGCAGG-3'
Reverse primer: 5'-AGATACAGGTCATTGGGC-3'
The pair of PCR primers can mutate 183 lysine AAG codon into succinic acid codon TAG, 1.25 microliter of forward primer and 1.25 microliter of reverse primer, 12.5 microliter of Q5 Hot Start High-Fidelity 2X Master Mix, 1 microliter of template containing DNA sequence of TurboID shown in SEQ ID NO. 2 and 9 microliter of water are mixed uniformly, and PCR amplification is carried out according to the following conditions: step 198 degree for 30 seconds; step 298 deg. 10 seconds; step 362 degree 15 seconds; step 472 ℃ for 5 minutes; step 5 repeats step 2 to step 4 25 times; step 672 degree 2 minutes.
Template utilization in a PCR reaction system is digested, and KLD mix is configured: 1 microliter of the PCR product, 5 microliter of 2 XKLD reaction, 1 microliter of 10 XKLD enzyme mixture, and 3 microliter of water were added. Incubate for 5 minutes at room temperature.
The above 1. mu.l of KLD mix was added to chemically competent E.coli and incubated on ice for 30 minutes.
The 42 degree heat shock was incubated on ice for 5 minutes after 30 seconds.
LB medium was added and incubated at 37 ℃ for 1 hour.
Competent E.coli cells were plated on agar plates containing the corresponding antibiotics. The plasmid TurboID-183 containing the base mutation shown in SEQ ID NO. 3 was obtained by Sanger DNA sequencing.
2) TurboID-183 plasmid was ligated with that mentioned in reference 9
Figure BDA0003073475050000051
And MNPYK-tRNA synthetase plasmid are transfected into Hela cell, and at the same time, the final concentration of 1mM unnatural amino acid MNPYK is added to accumulate and express to obtain the light-operated adjacent biotin ligase PC-TurboID-183-MNPYK shown in SEQ ID NO. 4.
After the ligase was expressed for 12 hours, the sample was irradiated with 365 nm-wavelength ultraviolet light for 1 minute to recover the biotin ligase activity by PC-TurboID-183-MNPYK (see FIG. 1).
The DNA sequence of SEQ ID NO 3, TurboID-183 is as follows:
aaagacaatactgtgcctctgaagctgatcgctctcctggctaatggcgagttccatagtggcgaacagctgggagaaaccctgggcatgtccagggccgctatcaacaagcacattcagactctgcgcgactggggcgtggacgtgttcaccgtgcccggaaagggctactctctgcccgagcctatcccgctgctgaacgctaaacagattctgggacagctggacggcgggagcgtggcagtcctgcctgtggtcgactccaccaatcagtacctgctggatcgaatcggcgagctgaagagtggggatgcttgcattgcagaatatcagcaggcagggagaggaagcagagggaggaaatggttctctccttttggagctaacctgtacctgagtatgttttggcgcctgaagcggggaccagcagcaatcggcctgggcccggtcatcggaattgtcatggcagaagcgctgcgaaagctgggagcagacaaggtgcgagtcaaatggcccaatgacctgtatctgcaggatagaTagctggcaggcatcctggtggagctggccggaataacaggcgatgctgcacagatcgtcattggcgccgggattaacgtggctatgaggcgcgtggaggaaagcgtggtcaatcagggctggatcacactgcaggaagcagggattaacctggacaggaatactctggccgctacgctgatccgagagctgcgggcagccctggaactgttcgagcaggaaggcctggctccatatctgccacggtgggagaagctggataacttcatcaatagacccgtga
agctgatcattggggacaaagagattttcgggattagccgggggattgataaacagggagccctgctgctggaac
aggacggagttatcaaaccctggatgggcggagaaatcagtctgcggtctgccgaaaag
4, the amino acid sequence of the PC-TurboID-183-MNPYK is as follows:
KDNTVPLKLIALLANGEFHSGEQLGETLGMSRAAINKHIQTLRDWGVDVFTVPGKGYSLPEPIPLLNAKQILGQLDGGSVAVLPVVDSTNQYLLDRIGELKSGDACIAEYQQAGRGSRGRKWFSPFGANLYLSMFWRLKRGPAAIGLGPVIGIVMAEALRKLGADKVRVKWPNDLYLQDR(MNPYK)LAGILVELAGITGDAAQIVIGAGINVAMRRVEESVVNQGWITLQEAGINLDRNTLAATLIRELRAALELFEQEGLAPYLPRWEKLDNFINRPVKLIIGDKEIFGISRGIDKQGALLLEQDGVIKPWMGGEISLRSAEK
example 2
Technical scheme for expressing and activating light-operated biotin ligase PC-TurboID-183-ONBK
TurboID-183 plasmid shown in SEQ ID NO. 3 and that mentioned in reference 10
Figure BDA0003073475050000061
And ONBK-tRNA synthetase plasmid is transfected into Hela cells, and simultaneously, the unnatural amino acid ONBK with the final concentration of 1mM is added, and the optically controlled adjacent biotin ligase PC-TurboID-183-ONBK shown in SEQ ID NO. 5 is obtained through accumulation and expression.
After the ligase was accumulated and expressed for 12 hours, the sample was irradiated with 365nm ultraviolet light for 1 minute to allow PC-TurboID-183-ONBK to recover the biotin ligase activity (see FIG. 1).
The amino acids of SEQ ID NO 5, PC-TurboID-183-ONBK are as follows:
KDNTVPLKLIALLANGEFHSGEQLGETLGMSRAAINKHIQTLRDWGVDVFTVPGKGYSLPEPIPLLNAKQILGQLDGGSVAVLPVVDSTNQYLLDRIGELKSGDACIAEYQQAGRGSRGRKWFSPFGANLYLSMFWRLKRGPAAIGLGPVIGIVMAEALRKLGADKVRVKWPNDLYLQDR(ONBK)LAGILVELAGITGDAAQIVIGAGINVAMRRVEESVVNQGWITLQEAGINLDRNTLAATLIRELRAALELFEQEGLAPYLPRWEKLDNFINRPVKLIIGDKEIFGISRGIDKQGALLLEQDGVIKPWMGGEISLRSAEK
example 3
Technical scheme for expressing and activating light-operated biotin ligase PC-TurboID-132-ONBY
The point mutation method described in example 1 mutated the codon of tyrosine 132 in TurboID to amber codon TAG to obtain TurboID-132 plasmid shown in SEQ ID NO. 6. The primers used for point mutations were as follows:
a forward primer: 5'-CTAACCTGTAgCTGAGTATGTTTTG-3'
Reverse primer: 5'-CTCCAAAAGGAGAGAACC-3'
TurboID-132 plasmid was ligated with that mentioned in reference 11
Figure BDA0003073475050000062
And ONBY-tRNA synthetase plasmid are transfected into Hela cell, and simultaneously, unnatural amino acid ONBY with the final concentration of 1mM is added, and the light-operated adjacent biotin ligase PC-TurboID-132-ONBY shown in SEQ ID NO. 7 is obtained through accumulation and expression.
After the ligase was accumulated and expressed for 12 hours, the sample was irradiated with 365nm ultraviolet light for 1 minute to recover the biotin ligase activity by PC-TurboID-ONBY-132 (see FIG. 1).
The DNA sequence of SEQ ID NO 6, TurboID-132 is as follows:
aaagacaatactgtgcctctgaagctgatcgctctcctggctaatggcgagttccatagtggcgaacagctgggagaaaccctgggcatgtccagggccgctatcaacaagcacattcagactctgcgcgactggggcgtggacgtgttcaccgtgcccggaaagggctactctctgcccgagcctatcccgctgctgaacgctaaacagattctgggacagctggacggcgggagcgtggcagtcctgcctgtggtcgactccaccaatcagtacctgctggatcgaatcggcgagctgaagagtggggatgcttgcattgcagaatatcagcaggcagggagaggaagcagagggaggaaatggttctctccttttggagctaacctgtaGctgagtatgttttggcgcctgaagcggggaccagcagcaatcggcctgggcccggtcatcggaattgtcatggcagaagcgctgcgaaagctgggagcagacaaggtgcgagtcaaatggcccaatgacctgtatctgcaggatagaaagctggcaggcatcctggtggagctggccggaataacaggcgatgctgcacagatcgtcattggcgccgggattaacgtggctatgaggcgcgtggaggaaagcgtggtcaatcagggctggatcacactgcaggaagcagggattaacctggacaggaatactctggccgctacgctgatccgagagctgcgggcagccctggaactgttcgagcaggaaggcctggctccatatctgccacggtgggagaagctggataacttcatcaatagacccgtgaagctgatcattggggacaaagagattttcgggattagccgggggattgataaacagggagccctgctgctggaacaggacggagttatcaaaccctggatgggcggagaaatcagtctgcggtctgccgaaaag
the amino acid sequence of SEQ ID NO 7, PC-TurboID-132-ONBY is as follows:
KDNTVPLKLIALLANGEFHSGEQLGETLGMSRAAINKHIQTLRDWGVDVFTVPGKGYSLPEPIPLLNAKQILGQLDGGSVAVLPVVDSTNQYLLDRIGELKSGDACIAEYQQAGRGSRGRKWFSPFGANL(ONBY)LSMFWRLKRGPAAIGLGPVIGIVMAEALRKLGADKVRVKWPNDLYLQDRKLAGILVELAGITGDAAQIVIGAGINVAMRRVEESVVNQGWITLQEAGINLDRNTLAATLIRELRAALELFEQEGLAPYLPRWEKLDNFINRPVKLIIGDKEIFGISRGIDKQGALLLEQDGVIKPWMGGEISLRSAEK
example 4
Technical scheme for expressing and activating light-operated biotin ligase PC-TurboID-172-MNPYK
Mutating the codon of the 172 th lysine in the TurboID into an amber codon TAG as described in example 1 to obtain a TurboID-172 plasmid shown as SEQ ID NO. 8;
the primers for point mutations were as follows:
a forward primer: 5'-GGTGCGAGTCtagTGGCCCAATG-3'
Reverse primer: 5'-TTGTCTGCTCCCAGCTTTC-3'
TurboID-172 plasmid was ligated with the plasmid mentioned in reference 9
Figure BDA0003073475050000071
And MNPYK-tRNA synthetase plasmid are transfected into Hela cell, and at the same time, the final concentration of 1mM unnatural amino acid MNPYK is added to accumulate and express to obtain the light-operated adjacent biotin ligase PC-TurboID-172-MNPYK shown in SEQ ID NO. 9.
After the ligase was expressed for 12 hours, the sample was irradiated with 365 nm-wavelength ultraviolet light for 1 minute to recover the biotin ligase activity by PC-TurboID-172-MNPYK (see FIG. 1).
The DNA sequence of SEQ ID NO 8, TurboID-172 is as follows:
aaagacaatactgtgcctctgaagctgatcgctctcctggctaatggcgagttccatagtggcgaacagctgggagaaaccctgggcatgtccagggccgctatcaacaagcacattcagactctgcgcgactggggcgtggacgtgttcaccgtgcccggaaagggctactctctgcccgagcctatcccgctgctgaacgctaaacagattctgggacagctggacggcgggagcgtggcagtcctgcctgtggtcgactccaccaatcagtacctgctggatcgaatcggcgagctgaagagtggggatgcttgcattgcagaatatcagcaggcagggagaggaagcagagggaggaaatggttctctccttttggagctaacctgtacctgagtatgttttggcgcctgaagcggggaccagcagcaatcggcctgggcccggtcatcggaattgtcatggcagaagcgctgcgaaagctgggagcagacaaggtgcgagtcTAGtggcccaatgacctgtatctgcaggatagaaagctggcaggcatcctggtggagctggccggaataacaggcgatgctgcacagatcgtcattggcgccgggattaacgtggctatgaggcgcgtggaggaaagcgtggtcaatcagggctggatcacactgcaggaagcagggattaacctggacaggaatactctggccgctacgctgatccgagagctgcgggcagccctggaactgttcgagcaggaaggcctggctccatatctgccacggtgggagaagctggataacttcatcaatagacccgtgaagctgatcattggggacaaagagattttcgggattagccgggggattgataaacagggagccctgctgctggaacaggacggagttatcaaaccctggatgggcggagaaatcagtctgcggtctgccgaaaag
the amino acid sequence of SEQ ID NO 9, PC-TurboID-172-MNPYK is as follows:
KDNTVPLKLIALLANGEFHSGEQLGETLGMSRAAINKHIQTLRDWGVDVFTVPGKGYSLPEPIPLLNAKQILGQLDGGSVAVLPVVDSTNQYLLDRIGELKSGDACIAEYQQAGRGSRGRKWFSPFGANLYLSMFWRLKRGPAAIGLGPVIGIVMAEALRKLGADKVRV(MNPYK)WPNDLYLQDRKLAGILVELAGITGDAAQIVIGAGINVAMRRVEESVVNQGWITLQEAGINLDRNTLAATLIRELRAALELFEQEGLAPYLPRWEKLDNFINRPVKLIIGDKEIFGISRGIDKQGALLLEQDGVIKPWMGGEISLRSAEK
example 5
Technical scheme for expressing and activating light-operated biotin ligase PC-TurboID-172-ONBK
TurboID-172 plasmid shown in SEQ ID NO. 8 and that mentioned in reference 10
Figure BDA0003073475050000081
And ONBK-tRNA synthetase plasmid is transfected into Hela cells, and simultaneously, the unnatural amino acid ONBK with the final concentration of 1mM is added, and the optically controlled adjacent biotin ligase PC-TurboID-172-ONBK shown in SEQ ID NO. 10 is obtained through accumulation and expression.
After the ligase was accumulated and expressed for 12 hours, the sample was irradiated with 365nm ultraviolet light for 1 minute to allow PC-TurboID-172-ONBK to recover the biotin ligase activity (see FIG. 1).
The amino acids of SEQ ID NO 10, PC-TurboID-172-ONBK are as follows:
KDNTVPLKLIALLANGEFHSGEQLGETLGMSRAAINKHIQTLRDWGVDVFTVPGKGYSLPEPIPLLNAKQILGQLDGGSVAVLPVVDSTNQYLLDRIGELKSGDACIAEYQQAGRGSRGRKWFSPFGANLYLSMFWRLKRGPAAIGLGPVIGIVMAEALRKLGADKVRV(ONBK)WPNDLYLQDRKLAGILVELAGITGDAAQIVIGAGINVAMRRVEESVVNQGWITLQEAGINLDRNTLAATLIRELRAALELFEQEGLAPYLPRWEKLDNFINRPVKLIIGDKEIFGISRGIDKQGALLLEQDGVIKPWMGGEISLRSAEK
as shown in FIG. 1, the conventional biotin ligase (described in reference 3) is first overexpressed in cells, and after a large amount of biotin is added from an exogenous source, the biotin modification of the adjacent protein (shown on the right side of A) [3 ]. However, during the gradual expression and accumulation process of the traditional adjacent biotin ligase in cells, biotin is carried out on adjacent proteins by using biotin and ATP in a culture medium, a higher background is formed, and the accurate identification of protein species by downstream mass spectrometry is interfered (shown on the left side of A). The light-controlled adjacent biotin ligase obtained in the embodiment of the invention can prevent the combination of the active center of the adjacent biotin ligase and ATP or biotin by inserting the unnatural amino acid MNPYK or ONBK at the 183 th site or 172 th site or inserting the unnatural amino acid ONBY at the 132 th site of the traditional adjacent biotin ligase, thereby inhibiting enzyme activity, eliminating the influence of background biotinylation on the identification result of an effective mass spectrum in the accumulation expression process, and recovering the activity of the biotin ligase by the light-controlled adjacent biotin ligase under the condition of irradiation of specific ultraviolet wavelength.
Example 6
Technical scheme for expressing biotin ligase TurboID-168-MNPYK
The point mutation method as described in example 1 mutated the codon for lysine 168 in TurboID to amber codon TAG and named the vector TurboID-168 plasmid.
The point mutations were performed using primers as follows:
a forward primer: 5'-GGGAGCAGACtAGGTGCGAGT-3'
Reverse primer: 5'-AGCTTTCGCAGCGCTTCT-3'
TurboID-168 plasmid was ligated with that mentioned in reference 9
Figure BDA0003073475050000091
And MNPYK-tRNA synthetase plasmid are transfected into Hela cell, and at the same time, the final concentration of 1mM unnatural amino acid MNPYK is added, and the adjacent biotin ligase TurboID-168-MNPYK containing the unnatural amino acid insertion shown in SEQ ID NO. 11 is obtained through accumulation and expression.
After the ligase accumulation was expressed for 12 hours, the sample was irradiated with 365 nm-wavelength ultraviolet light for 1 minute, and the change in the enzyme activity before and after irradiation was compared.
The amino acids of SEQ ID NO 11, TurboID-168-MNPYK are as follows:
KDNTVPLKLIALLANGEFHSGEQLGETLGMSRAAINKHIQTLRDWGVDVFTVPGKGYSLPEPIPLLNAKQILGQLDGGSVAVLPVVDSTNQYLLDRIGELKSGDACIAEYQQAGRGSRGRKWFSPFGANLYLSMFWRLKRGPAAIGLGPVIGIVMAEALRKLGAD(MNPYK)VRVKWPNDLYLQDRKLAGILVELAGITGDAAQIVIGAGINVAMRRVEESVVNQGWITLQEAGINLDRNTLAATLIRELRAALELFEQEGLAPYLPRWEKLDNFINRPVKLIIGDKEIFGISRGIDKQGALLLEQDGVIKPWMGGEISLRSAEK
example 7
Technical scheme for expressing biotin ligase TurboID-168-ONBK
The point mutation method as described in example 1 mutated the codon for lysine 168 in TurboID to amber codon TAG and named the vector TurboID-168 plasmid.
TurboID-168 plasmid was ligated with that mentioned in reference 10
Figure BDA0003073475050000092
And ONBK-tRNA synthetase plasmid is transfected into Hela cells, and simultaneously, the unnatural amino acid ONBK with the final concentration of 1mM is added, and the adjacent biotin ligase TurboID-168-ONBK containing the unnatural amino acid insertion shown in SEQ ID NO. 12 is obtained through accumulation and expression.
After the ligase was accumulated and expressed for 12 hours, the sample was irradiated with 365 nm-wavelength ultraviolet light for 1 minute, and the change in activity before and after irradiation was compared.
12, TurboID-168-ONBK protein sequence as follows:
KDNTVPLKLIALLANGEFHSGEQLGETLGMSRAAINKHIQTLRDWGVDVFTVPGKGYSLPEPIPLLNAKQILGQLDGGSVAVLPVVDSTNQYLLDRIGELKSGDACIAEYQQAGRGSRGRKWFSPFGANLYLSMFWRLKRGPAAIGLGPVIGIVMAEALRKLGAD(ONBK)VRVKWPNDLYLQDRKLAGILVELAGITGDAAQIVIGAGINVAMRRVEESVVNQGWITLQEAGINLDRNTLAATLIRELRAALELFEQEGLAPYLPRWEKLDNFINRPVKLIIGDKEIFGISRGIDKQGALLLEQDGVIKPWMGGEISLRSAEK
example 8
Technical scheme for expressing biotin ligase TurboID-111-ONBY
The point mutation method as described in example 1 mutated the 111 th tyrosine codon in TurboID to amber codon TAG and named the vector TurboID-111 plasmid.
The primers used for point mutations were as follows:
a forward primer: 5'-TTGCAGAATAgCAGCAGGCAG-3'
Reverse primer: 5'-TGCAAGCATCCCCACTCT-3'
TurboID-111 plasmid was ligated with that of reference 11
Figure BDA0003073475050000101
And ONBY-tRNA synthetase plasmid is transfected into Hela cell, and simultaneously the unnatural amino acid ONBY with the final concentration of 1mM is added, and the adjacent biotin ligase TurboID-111-ONBY containing the unnatural amino acid insertion shown in SEQ ID NO. 13 is obtained through accumulation and expression.
After 12 hours of the expression of the ligase accumulation, the sample was irradiated with 365 nm-wavelength ultraviolet light for 1 minute, and the change in activity before and after irradiation was compared.
13, TurboID-111-ONBY amino acid sequence as follows:
KDNTVPLKLIALLANGEFHSGEQLGETLGMSRAAINKHIQTLRDWGVDVFTVPGKGYSLPEPIPLLNAKQILGQLDGGSVAVLPVVDSTNQYLLDRIGELKSGDACIAE(ONBY)
QQAGRGSRGRKWFSPFGANLYLSMFWRLKRGPAAIGLGPVIGIVMAEALRKLGADKVRVKWPNDLYLQDRKLAGILVELAGITGDAAQIVIGAGINVAMRRVEESVVNQGWITLQEAGINLDRNTLAATLIRELRAALELFEQEGLAPYLPRWEKLDNFINRPVKLIIGDKEIFGISRGIDKQGALLLEQDGVIKPWMGGEISLRSAEK
biotinylated immunoblots of total protein were detected with Streptavidin-HRP (see fig. 2) with or without biotinylation reaction of samples of Hela cells containing the expression of proximal biotin ligase obtained in examples 1 to 8 above, with or without 365nm light irradiation (see fig. 2), specifically:
cell samples obtained after different treatments were treated with RIPA lysate containing protease inhibitor (Thermo Scientific)TM89900) on ice for 15 minutes, the protein concentration was determined using the BCA kit, the final protein concentration was adjusted to 1mg/mL for all samples, and NuPAGE was added at a final concentration of 1 ×TMLDS sample buffer (Thermo Scientific)TMNP0007), samples were heated at 70 ℃ for 10 minutes, 10. mu.l of each lane, using NuPAGE TM4 to 12% 15-well Bis-Tris mini-protein gel (Thermo Scientific)TMNP0323BOX) were performed on a 1 XNuPAGETMSeparating at 80V for 1 hr in MOPS buffer (NP0001) system by NuPAGETMTransfer buffer (Thermo Scientific)TMNP0006) spin-transfer the PVDF membrane at a current of 200mA for 1 hour, block the transferred PVDF membrane with PBS containing 5% BSA for 1 hourIn PBS buffer, according to 1: Streptavidin-HRP (Abcam, ab7403) was diluted at a ratio of 5000(v/v) and incubated at room temperature for half an hour, and the PVDF membrane was washed 5 times for 5 minutes each with PBS. Joining PierceTMECL reaction substrate (Thermo Scientific)TM32106) reaction for 1 minute, and exposing on a weather chemiluminometer (Tanon 4600FS) to collect light signals.
Wherein, the specific sequence of different treatment conditions (i.e. lanes 1-18 in FIG. 2) is:
TurboID plasmid was transfected, 12 hours later, no biotin was added.
TurboID plasmid was transfected, and 12 hours later, biotin was added to a final concentration of 0.5mM for reaction at 37 ℃ for 10 minutes.
Transfection of TurboID-183 and
Figure BDA0003073475050000111
and MNPYK-tRNA synthetase plasmid and 1mM MNPYK unnatural amino acid are added simultaneously, after 12 hours, the ultraviolet irradiation with 365nm wavelength is not needed, and biotin with the final concentration of 0.5mM is added for reaction at 37 ℃ for 10 minutes.
Transfection of TurboID-183 and
Figure BDA0003073475050000112
adding 1mM MNPYK unnatural amino acid into MNPYK-tRNA synthetase plasmid, after 12 hours, carrying out ultraviolet irradiation for 1 minute by using 365nm wavelength, adding biotin with the final concentration of 0.5mM at 37 ℃, and reacting for 10 minutes
Transfection of TurboID-183 and
Figure BDA0003073475050000113
1mM ONBK unnatural amino acid was added simultaneously with the ONBK-tRNA synthetase plasmid, and after 12 hours, biotin was added to the final concentration of 0.5mM for 10 minutes at 37 ℃ without UV irradiation at a wavelength of 365 nm.
Transfection of TurboID-183 and
Figure BDA0003073475050000114
adding 1mM ONBK unnatural amino acid together with the ONBK-tRNA synthetase plasmid, after 12 hours, ultraviolet irradiating for 1 minute at 365nm wavelength, adding final concentration of 0.5mMBiotin was reacted at 37 ℃ for 10 minutes.
Transfection of TurboID-132 and
Figure BDA0003073475050000115
and ONBY-tRNA synthetase plasmid, 1mM ONBY unnatural amino acid was added, and after 12 hours, biotin was added to the resulting mixture at 37 ℃ to react for 10 minutes without UV irradiation at 365 nm.
Transfection of TurboID-132 and
Figure BDA0003073475050000116
and ONBY-tRNA synthetase plasmid, adding 1mM ONBY unnatural amino acid, after 12 hr, irradiating with 365nm ultraviolet light for 1 min, adding biotin at 37 deg.C to final concentration of 0.5mM, and reacting for 10 min.
Transfection of TurboID-168 and
Figure BDA0003073475050000117
and MNPYK-tRNA synthetase plasmid and 1mM MNPYK unnatural amino acid are added simultaneously, after 12 hours, the ultraviolet irradiation with 365nm wavelength is not needed, and biotin with the final concentration of 0.5mM is added for reaction at 37 ℃ for 10 minutes.
Transfection of TurboID-168 and
Figure BDA0003073475050000118
adding 1mM MNPYK unnatural amino acid into MNPYK-tRNA synthetase plasmid, after 12 hours, irradiating the MNPYK unnatural amino acid by using 365nm wavelength ultraviolet rays for 1 minute, and adding biotin with the final concentration of 0.5mM to react for 10 minutes at 37 ℃.
Transfection of TurboID-168 and
Figure BDA0003073475050000119
1mM ONBK unnatural amino acid was added simultaneously with the ONBK-tRNA synthetase plasmid, and after 12 hours, biotin was added to the final concentration of 0.5mM for 10 minutes at 37 ℃ without UV irradiation at a wavelength of 365 nm.
Transfection of TurboID-168 and
Figure BDA00030734750500001110
and ONBK-tRNA synthetase plasmidSimultaneously adding 1mM ONBK unnatural amino acid, after 12 hours, carrying out ultraviolet irradiation for 1 minute by using a wavelength of 365 nanometers, and adding biotin with a final concentration of 0.5mM for reacting for 10 minutes at 37 ℃.
Transfection of TurboID-111 and
Figure BDA00030734750500001111
and ONBY-tRNA synthetase plasmid, 1mM ONBY unnatural amino acid was added, and after 12 hours, biotin was added to the resulting mixture at 37 ℃ to react for 10 minutes without UV irradiation at 365 nm.
Transfection of TurboID-111 and
Figure BDA00030734750500001112
and ONBY-tRNA synthetase plasmid, adding 1mM ONBY unnatural amino acid, after 12 hr, irradiating with 365nm ultraviolet light for 1 min, adding biotin at 37 deg.C to final concentration of 0.5mM, and reacting for 10 min.
Transfection of TurboID-172 and
Figure BDA0003073475050000121
and MNPYK-tRNA synthetase plasmid and 1mM MNPYK unnatural amino acid are added simultaneously, after 12 hours, the ultraviolet irradiation with 365nm wavelength is not needed, and biotin with the final concentration of 0.5mM is added for reaction at 37 ℃ for 10 minutes.
Transfection of TurboID-172 and
Figure BDA0003073475050000122
adding 1mM MNPYK unnatural amino acid into MNPYK-tRNA synthetase plasmid, after 12 hours, carrying out ultraviolet irradiation for 1 minute by using 365nm wavelength, adding biotin with the final concentration of 0.5mM at 37 ℃, and reacting for 10 minutes
Transfection of TurboID-172 and
Figure BDA0003073475050000123
1mM ONBK unnatural amino acid was added simultaneously with the ONBK-tRNA synthetase plasmid, and after 12 hours, biotin was added to the final concentration of 0.5mM for 10 minutes at 37 ℃ without UV irradiation at a wavelength of 365 nm.
Transfection of TurboID-172 and
Figure BDA0003073475050000124
and ONBK-tRNA synthetase plasmid simultaneously with 1mM ONBK unnatural amino acid, 12 hours later, using 365nm wavelength ultraviolet radiation for 1 minutes, adding 0.5mM biotin final concentration 37 degrees reaction for 10 minutes.
As can be seen from fig. 2, first, comparison of lanes 1 and 2 shows that the biotin ligase TurboID in the vicinity is capable of biotinylation of a neighboring protein with exogenously added biotin within a reaction time of 10 minutes, which is consistent with the conclusion reported in the previous document 3; second, it can be shown from lanes 3, 5, 7, 15 and 17 that after insertion of the unnatural amino acid MNPYK (shown in lane 3) or ONBK (shown in lane 5) at position 183 or insertion of the unnatural amino acid ONBY (shown in lane 7) at position 132 or insertion of the unnatural amino acid MNPYK (shown in lane 15) or ONBK (shown in lane 17) at position 172, biotinylation reaction cannot occur even when biotin is added exogenously, which demonstrates that insertion of the unnatural amino acid at position 183 or position 132 or position 172 of TurboID can block biotin ligase activity; third, comparison of Lane 3 with Lane 4, Lane 5 with Lane 6, Lane 7 with Lane 8, Lane 15 with Lane 16, and Lane 17 with Lane 18 shows that PC-TurboID-183-MNPYK (Lane 3 with Lane 4), PC-TurboID-183-ONBK (Lane 5 with Lane 6), PC-TurboID-ONBY-132 (Lane 7 with Lane 8) PC-TurboID-172-MNPYK (Lane 15 with Lane 16) and PC-TurboID-172-ONBK (Lane 17 with Lane 18) all restore the biotin ligase activity after 1 minute of 365nm illumination, and that TurboID-MNPYK-183 (Lane 4) has a better activity than wild-TurboID (Lane 2) and a better activity than that of TurboID-183-ONBK (Lane 6), PC-TurboID-ONBY-132 (lane 8), PC-TurboID-172-MNPYK (lane 16), and PC-TurboID-172-ONBK (lane 18), which are probably due to the following two reasons: (1) the sensitivity of different unnatural amino acids to 365nm wavelength radiation is different. Specifically, ONBK and ONBY (ONB group modified lysine and tyrosine) are not completely converted into wild-type lysine and tyrosine under the condition of 1 minute of 365nm illumination, while MNPYK (MNPY modified lysine) can be completely converted into wild-type lysine under the condition of 1 minute of 365nm illumination, and (2) the insertion of ONBK and ONBY into 183 or 132 of TurboID or the insertion of MNPYK into 172 of TurboID leads to the reduction of the stability of TurboID and is more easily degraded by proteasome in cells, while the insertion of MNPYK into 183 of TurboID has no influence on the stability of TurboID; fourth, comparison of the 3 rd, 5 th, 7 th, 15 th and 17 th lanes with the 1 st lane shows that the insertion of MNPYK (3 rd lane) and ONBK (5 th lane) at 183 th or the insertion of ONBY (7 th lane) at 132 th or the insertion of MNPYK (15 th lane) and ONBK (17 th lane) at 172 nd of TurboID significantly eliminates the biotinylated background due to the accumulation expression of TurboID (1 st lane); fifthly, comparing the 9 th lane with the 10 th lane, the 11 th lane with the 12 th lane and the 13 th lane with the 14 th lane, it is shown that the insertion of the unnatural amino acid MNPYK (9 th lane and 10 th lane) or ONBK (11 th lane and 12 th lane) at the 168 position of TurboID and the insertion of the unnatural amino acid ONBY (13 th lane and 14 th lane) at the 111 position of TurboID are not changed, whether the lighting is carried out at 365nm for 1 minute, which proves that the insertion of the unnatural amino acid only at the specific site of TurboID can block the biotin ligase activity, and the nonspecific effect of the unnatural amino acid system on the biotin ligase activity of TurboID is excluded.
Application example 1
The light-controlled biotin ligase obtained by the embodiment is used for mass spectrometric identification, and specifically:
taking the example of obtaining the light-controlled biotin ligase PC-TurboID-183-MNPYK in example 1, after fusion expression of the neighboring biotin ligase and the target protein, irradiation is performed at 365nm to restore the enzyme activity of the neighboring biotin ligase, so as to perform biotin labeling on the neighboring protein of the target protein, and the biotin-labeled protein is enriched by Streptavidin coupled magnetic beads for mass spectrometry (see fig. 3). Among them, Stable Isotope Labeling technology (SILAC) under Cell Culture conditions can be used to distinguish cells under different treatment conditions, i.e., 365nm illumination or no illumination.
The method further comprises the following steps:
according to the mitochondrial localization sequence mentioned in reference [3], the mitochondrial matrix localization sequence was fused with TurboID-183 described in SEQ ID NO:3 to obtain mito-TurboID-183 shown in SEQ ID NO:14 by gene synthesis.
The DNA sequence of SEQ ID NO 14mito-TurboID-183 is as follows:
ATGCTCGCCACGAGGGTGTTCTCTCTGGTGGGAAAAAGAGCGATTTCAACCAGTGTGTGTGTCAGAGCCCACGGGGGCAGCGGAGGAaaagacaatactgtgcctctgaagctgatcgctctcctggctaatggcgagttccatagtggcgaacagctgggagaaaccctgggcatgtccagggccgctatcaacaagcacattcagactctgcgcgactggggcgtggacgtgttcaccgtgcccggaaagggctactctctgcccgagcctatcccgctgctgaacgctaaacagattctgggacagctggacggcgggagcgtggcagtcctgcctgtggtcgactccaccaatcagtacctgctggatcgaatcggcgagctgaagagtggggatgcttgcattgcagaatatcagcaggcagggagaggaagcagagggaggaaatggttctctccttttggagctaacctgtacctgagtatgttttggcgcctgaagcggggaccagcagcaatcggcctgggcccggtcatcggaattgtcatggcagaagcgctgcgaaagctgggagcagacaaggtgcgagtcaaatggcccaatgacctgtatctgcaggatagaTagctggcaggcatcctggtggagctggccggaataacaggcgatgctgcacagatcgtcattggcgccgggattaacgtggctatgaggcgcgtggaggaaagcgtggtcaatcagggctggatcacactgcaggaagcagggattaacctggacaggaatactctggccgctacgctgatccgagagctgcgggcagccctggaactgttcgagcaggaaggcctggctccatatctgccacggtgggagaagctggataacttcatcaatagacccgtgaagctgatcattggggacaaagagattttcgggattagccgggggattgataaacagggagccctgctgctggaacaggacggagttatcaaaccctggatgggcggagaaatcagtctgcggtctgccgaaaag
stable Isotope Labeling technology (Stable Isotope Labeling By Amino Acids In Cell Culture, SILAC) under Cell Culture conditions is a technology for quantitative analysis of protein expression By using Stable Isotope labeled Amino Acids In combination with mass spectrometry technology In the Cell Culture process. In this application, L-Arginine-HCl with a final concentration of 73mg/L, 13C6,15N4 and 146 mg/L-Lysine-2 HCl and 13C6 were added to a heavy standard medium, and 73 mg/L-Arginine-HCl and 146 mg/L-Lysine-2 HCl were added to a light standard medium, and cells were cultured for 5 generations in the heavy standard and light standard media, whereby isotopic labeling of 99% or more of the proteins in the cells was achieved.
By co-transfection of mito-TurboID-183 plasmid as shown in SEQ ID NO 11 and the unnatural amino acid insertion System mentioned in reference 9 in heavy-and light-targeted cells
Figure BDA0003073475050000142
Figure BDA0003073475050000141
And MNPYK-tRNA synthetase, and adding a final concentration of 1mM unnatural amino acid MNPYK simultaneously, thereby specifically inserting the MNPYK into the 183 rd lysine position of the TurboID to obtain the mitochondrially targeted light-operated adjacent biotin ligase PC-mito-TurboID-183-MNPYK shown in SEQ ID NO. 15.
The protein sequence of SEQ ID NO 15PC-mito-TurboID-183-MNPYK is as follows:
MLATRVFSLVGKRAISTSVCVRAHGGSGGKDNTVPLKLIALLANGEFHSGEQLGETLGMSRAAINKHIQTLRDWGVDVFTVPGKGYSLPEPIPLLNAKQILGQLDGGSVAVLPVVDSTNQYLLDRIGELKSGDACIAEYQQAGRGSRGRKWFSPFGANLYLSMFWRLKRGPAAIGLGPVIGIVMAEALRKLGADKVRVKWPNDLYLQDR(MNPYK)LAGILVELAGITGDAAQIVIGAGINVAMRRVEESVVNQGWITLQEAGINLDRNTLAATLIRELRAALELFEQEGLAPYLPRWEKLDNFINRPVKLIIGDKEIFGISRGIDKQGALLLEQDGVIKPWMGGEISLRSAEK
after accumulating and expressing the PC-mito-TurboID-183-MNPYK for 12 hours, illuminating the cells cultured in the heavy-duty culture medium for 1 minute at 365nm, and not illuminating the cells in the light-duty culture medium; adding biotin with the final concentration of 0.5mM, reacting for 10 minutes at 37 ℃, cracking cells, mixing heavy-label cell lysate and light-label cell lysate with equal mass, enriching biotinylated protein by Streptavidin coupled magnetic beads, and identifying the enriched biotinylated protein by mass spectrometry. The ratio of the abundance of the peptide fragments in the heavy-standard sample and the light-standard sample can reflect the protein biotinylated by the PC-mito-TurboID-183-MNPYK after being specifically photoactivated.
As shown in FIG. 3, the conventional method for constructing TurboID fusion to express mitochondrial signal peptide, mito-TurboID [3] (described in reference 3) can biotinylate proteins in mitochondrial matrix, and researchers have identified 212 mitochondrial matrix proteins using mito-TurboID with specificity of only 67% (FIG. 3B, bottom). Using the same biological assay scheme [3] as reported in the previous literature, PC-mito-TurboID-183-MNPYK was able to identify 194 mitochondrial matrix proteins with specificity as high as 91%, whereas the classical proximal biotin ligase was only 67% specific. Therefore, the light-controlled adjacent biotin ligase is significantly superior to the conventional adjacent biotin ligase in the specificity of identifying proteins in specific organelles.
1.Choi-Rhee,E.,H.Schulman,and J.E.Cronan,Promiscuous protein biotinylation by Escherichia coli biotin protein ligase.Protein Sci,2004.13(11):p.3043-50.
2.Roux,K.J.,et al.,A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells.Journal of Cell Biology,2012.196(6):p.801-810.
3.Branon,T.C.,et al.,Efficient proximity labeling in living cells and organisms with TurboID.Nat Biotechnol,2018.36(9):p.880-887.
4.Rhee,H.W.,et al.,Proteomic mapping of mitochondria in living cells via spatially restricted enzymatic tagging.Science,2013.339(6125):p.1328-1331.
5.Mair,A.,et al.,Proximity labeling of protein complexes and cell-type-specific organellar proteomes in Arabidopsis enabled by TurboID.Elife,2019.8.
6.Zhang,B.,Y.Zhang,and J.L.Liu,Highly effective proximate labeling in Drosophila.G3(Bethesda),2021.
7.Srinivasan,G.,C.M.James,and J.A.Krzycki,Pyrrolysine encoded by UAG in Archaea:charging of a UAG-decoding specialized tRNA.Science,2002.296(5572):p.1459-62.
8.Wang,L.,et al.,Expanding the genetic code of Escherichia coli.Science,2001.292(5516):p.498-500.
9.Gautier,A.,et al.,Genetically encoded photocontrol of protein localization in mammalian cells.J Am Chem Soc,2010.132(12):p.4086-8.
10.Chen,P.R.,et al.,A facile system for encoding unnatural amino acids in mammalian cells.Angew Chem Int Ed Engl,2009.48(22):p.4052-5.
11.Arbely,E.,et al.,Photocontrol of tyrosine phosphorylation in mammalian cells via genetic encoding of photocaged tyrosine.J Am Chem Soc,2012.134(29):p.11912-5.
Sequence listing
<110> institute of biophysics of Chinese academy of sciences
<120> a biotin ligase and uses thereof
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 957
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
aaagacaata ctgtgcctct gaagctgatc gctctcctgg ctaatggcga gttccatagt 60
ggcgaacagc tgggagaaac cctgggcatg tccagggccg ctatcaacaa gcacattcag 120
actctgcgcg actggggcgt ggacgtgttc accgtgcccg gaaagggcta ctctctgccc 180
gagcctatcc cgctgctgaa cgctaaacag attctgggac agctggacgg cgggagcgtg 240
gcagtcctgc ctgtggtcga ctccaccaat cagtacctgc tggatcgaat cggcgagctg 300
aagagtgggg atgcttgcat tgcagaatat cagcaggcag ggagaggaag cagagggagg 360
aaatggttct ctccttttgg agctaacctg tacctgagta tgttttggcg cctgaagcgg 420
ggaccagcag caatcggcct gggcccggtc atcggaattg tcatggcaga agcgctgcga 480
aagctgggag cagacaaggt gcgagtcaaa tggcccaatg acctgtatct gcaggataga 540
aagctggcag gcatcctggt ggagctggcc ggaataacag gcgatgctgc acagatcgtc 600
attggcgccg ggattaacgt ggctatgagg cgcgtggagg aaagcgtggt caatcagggc 660
tggatcacac tgcaggaagc agggattaac ctggacagga atactctggc cgctacgctg 720
atccgagagc tgcgggcagc cctggaactg ttcgagcagg aaggcctggc tccatatctg 780
ccacggtggg agaagctgga taacttcatc aatagacccg tgaagctgat cattggggac 840
aaagagattt tcgggattag ccgggggatt gataaacagg gagccctgct gctggaacag 900
gacggagtta tcaaaccctg gatgggcgga gaaatcagtc tgcggtctgc cgaaaag 957
<210> 2
<211> 957
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
aaagacaata ctgtgcctct gaagctgatc gctctcctgg ctaatggcga gttccatagt 60
ggcgaacagc tgggagaaac cctgggcatg tccagggccg ctatcaacaa gcacattcag 120
actctgcgcg actggggcgt ggacgtgttc accgtgcccg gaaagggcta ctctctgccc 180
gagcctatcc cgctgctgaa cgctaaacag attctgggac agctggacgg cgggagcgtg 240
gcagtcctgc ctgtggtcga ctccaccaat cagtacctgc tggatcgaat cggcgagctg 300
aagagtgggg atgcttgcat tgcagaatat cagcaggcag ggagaggaag cagagggagg 360
aaatggttct ctccttttgg agctaacctg tacctgagta tgttttggcg cctgaagcgg 420
ggaccagcag caatcggcct gggcccggtc atcggaattg tcatggcaga agcgctgcga 480
aagctgggag cagacaaggt gcgagtcaaa tggcccaatg acctgtatct gcaggataga 540
tagctggcag gcatcctggt ggagctggcc ggaataacag gcgatgctgc acagatcgtc 600
attggcgccg ggattaacgt ggctatgagg cgcgtggagg aaagcgtggt caatcagggc 660
tggatcacac tgcaggaagc agggattaac ctggacagga atactctggc cgctacgctg 720
atccgagagc tgcgggcagc cctggaactg ttcgagcagg aaggcctggc tccatatctg 780
ccacggtggg agaagctgga taacttcatc aatagacccg tgaagctgat cattggggac 840
aaagagattt tcgggattag ccgggggatt gataaacagg gagccctgct gctggaacag 900
gacggagtta tcaaaccctg gatgggcgga gaaatcagtc tgcggtctgc cgaaaag 957
<210> 3
<211> 957
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
aaagacaata ctgtgcctct gaagctgatc gctctcctgg ctaatggcga gttccatagt 60
ggcgaacagc tgggagaaac cctgggcatg tccagggccg ctatcaacaa gcacattcag 120
actctgcgcg actggggcgt ggacgtgttc accgtgcccg gaaagggcta ctctctgccc 180
gagcctatcc cgctgctgaa cgctaaacag attctgggac agctggacgg cgggagcgtg 240
gcagtcctgc ctgtggtcga ctccaccaat cagtacctgc tggatcgaat cggcgagctg 300
aagagtgggg atgcttgcat tgcagaatat cagcaggcag ggagaggaag cagagggagg 360
aaatggttct ctccttttgg agctaacctg tagctgagta tgttttggcg cctgaagcgg 420
ggaccagcag caatcggcct gggcccggtc atcggaattg tcatggcaga agcgctgcga 480
aagctgggag cagacaaggt gcgagtcaaa tggcccaatg acctgtatct gcaggataga 540
aagctggcag gcatcctggt ggagctggcc ggaataacag gcgatgctgc acagatcgtc 600
attggcgccg ggattaacgt ggctatgagg cgcgtggagg aaagcgtggt caatcagggc 660
tggatcacac tgcaggaagc agggattaac ctggacagga atactctggc cgctacgctg 720
atccgagagc tgcgggcagc cctggaactg ttcgagcagg aaggcctggc tccatatctg 780
ccacggtggg agaagctgga taacttcatc aatagacccg tgaagctgat cattggggac 840
aaagagattt tcgggattag ccgggggatt gataaacagg gagccctgct gctggaacag 900
gacggagtta tcaaaccctg gatgggcgga gaaatcagtc tgcggtctgc cgaaaag 957
<210> 4
<211> 957
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
aaagacaata ctgtgcctct gaagctgatc gctctcctgg ctaatggcga gttccatagt 60
ggcgaacagc tgggagaaac cctgggcatg tccagggccg ctatcaacaa gcacattcag 120
actctgcgcg actggggcgt ggacgtgttc accgtgcccg gaaagggcta ctctctgccc 180
gagcctatcc cgctgctgaa cgctaaacag attctgggac agctggacgg cgggagcgtg 240
gcagtcctgc ctgtggtcga ctccaccaat cagtacctgc tggatcgaat cggcgagctg 300
aagagtgggg atgcttgcat tgcagaatat cagcaggcag ggagaggaag cagagggagg 360
aaatggttct ctccttttgg agctaacctg tacctgagta tgttttggcg cctgaagcgg 420
ggaccagcag caatcggcct gggcccggtc atcggaattg tcatggcaga agcgctgcga 480
aagctgggag cagacaaggt gcgagtctag tggcccaatg acctgtatct gcaggataga 540
aagctggcag gcatcctggt ggagctggcc ggaataacag gcgatgctgc acagatcgtc 600
attggcgccg ggattaacgt ggctatgagg cgcgtggagg aaagcgtggt caatcagggc 660
tggatcacac tgcaggaagc agggattaac ctggacagga atactctggc cgctacgctg 720
atccgagagc tgcgggcagc cctggaactg ttcgagcagg aaggcctggc tccatatctg 780
ccacggtggg agaagctgga taacttcatc aatagacccg tgaagctgat cattggggac 840
aaagagattt tcgggattag ccgggggatt gataaacagg gagccctgct gctggaacag 900
gacggagtta tcaaaccctg gatgggcgga gaaatcagtc tgcggtctgc cgaaaag 957

Claims (9)

1.一种邻近生物素连接酶,其特征在于:邻近生物素连接酶为生物素连接酶中位于ATP或者生物素结合口袋的催化中心位点附近定点插入非天然氨基酸。1. An adjacent biotin ligase, characterized in that: the adjacent biotin ligase is a site-specific insertion of unnatural amino acids near the catalytic center site of ATP or a biotin binding pocket in the biotin ligase. 2.按权利要求1所述的邻近生物素连接酶,其特征在于:所述邻近生物素连接酶为大肠杆菌来源的生物素连接酶BirA的突变体的氨基酸序列中第183位赖氨酸、132位酪氨酸、第172位赖氨酸中的一个或几个位点突变为非天然氨基酸,从而抑制该邻近生物素连接酶的酶活。2. The adjacent biotin ligase according to claim 1, wherein the adjacent biotin ligase is the 183rd lysine in the amino acid sequence of the mutant of the biotin ligase BirA derived from Escherichia coli, One or several sites of tyrosine at position 132 and lysine at position 172 are mutated into unnatural amino acids, thereby inhibiting the enzymatic activity of the adjacent biotin ligase. 3.按权利要求2所述的邻近生物素连接酶,其特征在于:所述邻近生物素连接酶为生物素连接酶TurboID的氨基酸序列中第183位赖氨酸、132位酪氨酸、第172位赖氨酸中的一个或几个位点突变为非天然氨基酸;其中,非天然氨基酸为非天然氨基酸MNPY-赖氨酸或ONB-赖氨酸或ONB-酪氨酸。3. according to the described adjacent biotin ligase of claim 2, it is characterized in that: described adjacent biotin ligase is the 183rd lysine, the 132nd tyrosine, the 183th lysine, the 132nd tyrosine in the amino acid sequence of the biotin ligase TurboID One or several sites in the 172-position lysine are mutated into an unnatural amino acid; wherein, the unnatural amino acid is the unnatural amino acid MNPY-lysine or ONB-lysine or ONB-tyrosine. 4.按权利要求3所述的邻近生物素连接酶,其特征在于:所述邻近生物素连接酶为SEQID NO:1所示氨基酸序列中第183位赖氨酸突变为非天然氨基酸MNPY-赖氨酸或非天然氨基酸ONB-赖氨酸,即SEQ ID NO:4所示氨基酸序列、SEQ ID NO:5所示氨基酸序列;4. The adjacent biotin ligase according to claim 3, wherein the adjacent biotin ligase is that the 183rd lysine in the amino acid sequence shown in SEQID NO:1 is mutated to an unnatural amino acid MNPY-lysine amino acid or unnatural amino acid ONB-lysine, namely the amino acid sequence shown in SEQ ID NO:4, the amino acid sequence shown in SEQ ID NO:5; 或,SEQ ID NO:1所示氨基酸序列中第132位酪氨酸突变为非天然氨基酸ONB-酪氨酸,即SEQ ID NO:7所示氨基酸序列;Or, in the amino acid sequence shown in SEQ ID NO:1, the tyrosine at position 132 is mutated to the unnatural amino acid ONB-tyrosine, that is, the amino acid sequence shown in SEQ ID NO:7; 或,SEQ ID NO:1所示氨基酸序列中第172位赖氨酸突变为非天然氨基酸MNPY-赖氨酸或非天然氨基酸ONB-赖氨酸,即SEQ ID NO:9所示氨基酸序列、SEQ ID NO:10所示氨基酸序列。Or, the 172nd lysine in the amino acid sequence shown in SEQ ID NO:1 is mutated to unnatural amino acid MNPY-lysine or unnatural amino acid ONB-lysine, that is, the amino acid sequence shown in SEQ ID NO:9, SEQ ID NO:9 The amino acid sequence shown in ID NO: 10. 5.一种权利要求1所述的邻近生物素连接酶的构建方法,其特征在于:对生物素连接酶TurboID的邻近ATP或者生物素结合口袋的催化中心位点附近两个位点,利用正交的
Figure FDA0003073475040000011
和吡咯烷基-tRNA合成酶进行定点非天然氨基酸插入,获得邻近生物素连接酶。
5. the construction method of the described adjacent biotin ligase of claim 1, is characterized in that: to the adjacent ATP of biotin ligase TurboID or two sites near the catalytic center site of biotin binding pocket, utilize positive made
Figure FDA0003073475040000011
Site-directed insertion of unnatural amino acids with pyrrolidinyl-tRNA synthetase to obtain adjacent biotin ligase.
6.按权利要求5所述的邻近生物素连接酶的构建方法,其特征在于:所述生物素连接酶TurboID氨基酸序列如SEQ ID NO:1所示;非天然氨基酸为非天然氨基酸MNPY-赖氨酸或非天然氨基酸ONB-赖氨酸或ONB-酪氨酸。6. by the construction method of the described adjacent biotin ligase of claim 5, it is characterized in that: described biotin ligase TurboID amino acid sequence is as shown in SEQ ID NO: 1; Unnatural amino acid is unnatural amino acid MNPY-lysine amino acid or the unnatural amino acid ONB-lysine or ONB-tyrosine. 7.一种权利要求1所述的邻近生物素连接酶的应用,其特征在于:所述邻近生物素连接酶在质谱鉴定中的应用。7 . The application of the adjacent biotin ligase according to claim 1 , wherein the application of the adjacent biotin ligase in mass spectrometry identification. 8 . 8.按权利要求7所述的邻近生物素连接酶的应用,其特征在于:所述权利要求1-4中记载任意一个邻近生物素连接酶在特定紫外波长光照条件下,对邻近蛋白进行生物素标记及其在质谱鉴定中的应用。8. by the application of the described adjacent biotin ligase of claim 7, it is characterized in that: record any adjacent biotin ligase in the described claim 1-4 under specific ultraviolet wavelength illumination conditions, carry out biological treatment to adjacent protein Element labeling and its application in mass spectrometry identification. 9.一种利用邻近生物素连接酶进行生物素化标记进而进行质谱鉴定的方法,其特征在于:利用权利要求1-4中记载任意一个邻近生物素连接酶,与目的蛋白融合表达后,定位到特定细胞结构,而后特定紫外波长照射,使邻近生物素连接酶恢复酶活性,进而对目的蛋白的邻近蛋白进行生物素标记,被生物素标记的蛋白通过Streptavidin耦联磁珠富集,进行质谱鉴定。9. a kind of method that utilizes adjacent biotin ligase to carry out biotinylation labeling and then carries out mass spectrometry identification, it is characterized in that: utilize any adjacent biotin ligase to record in claim 1-4, after fusion expression with target protein, locate After reaching a specific cell structure, and then irradiating with a specific ultraviolet wavelength, the adjacent biotin ligase restores the enzymatic activity, and then biotin-labels the adjacent protein of the target protein. The biotin-labeled protein is enriched by Streptavidin-coupled magnetic beads for mass spectrometry. identification.
CN202110545864.1A 2021-05-19 2021-05-19 Proximal biotin ligase and application thereof Active CN113481173B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110545864.1A CN113481173B (en) 2021-05-19 2021-05-19 Proximal biotin ligase and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110545864.1A CN113481173B (en) 2021-05-19 2021-05-19 Proximal biotin ligase and application thereof

Publications (2)

Publication Number Publication Date
CN113481173A true CN113481173A (en) 2021-10-08
CN113481173B CN113481173B (en) 2022-10-14

Family

ID=77932933

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110545864.1A Active CN113481173B (en) 2021-05-19 2021-05-19 Proximal biotin ligase and application thereof

Country Status (1)

Country Link
CN (1) CN113481173B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114149980A (en) * 2021-11-04 2022-03-08 中山大学 A Novel Protein Biotin Ligase and Its Based Proximity Labeling System PhastID
CN114457048A (en) * 2022-02-11 2022-05-10 中山大学 A protein biotin ligase and its adjacent protein labeling system and application
CN114606208A (en) * 2022-03-31 2022-06-10 中山大学 A high-confidence and rapid proximity protein labeling system ScPhastID and labeling method
CN116162152A (en) * 2022-12-23 2023-05-26 华中科技大学同济医学院附属同济医院 Preparation method and application of biotinylated monoclonal antibody
CN118207171A (en) * 2024-05-21 2024-06-18 北京量维生物科技研究院有限公司 Biotin ligase mutant and its use in biotin production

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104450746A (en) * 2014-08-30 2015-03-25 武汉佰福泰制药有限公司 Method for fixed-point introduction of non-natural amino acid to protein
US20190185836A1 (en) * 2016-09-02 2019-06-20 The Regents Of The University Of California Engineered subtiligase variants for versatile, site-specific labeling of proteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104450746A (en) * 2014-08-30 2015-03-25 武汉佰福泰制药有限公司 Method for fixed-point introduction of non-natural amino acid to protein
US20190185836A1 (en) * 2016-09-02 2019-06-20 The Regents Of The University Of California Engineered subtiligase variants for versatile, site-specific labeling of proteins

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHAN HYUK KIM等: "Protein conjugation with genetically encoded unnatural amino acids", 《CURRENT OPINION IN CHEMICAL BIOLOGY》 *
JARED A. SHADISH等: "Site-Selective Protein Modification: From Functionalized Proteins to Functional Biomaterials", 《MATTER》 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114149980A (en) * 2021-11-04 2022-03-08 中山大学 A Novel Protein Biotin Ligase and Its Based Proximity Labeling System PhastID
CN114149980B (en) * 2021-11-04 2023-10-13 中山大学 A novel protein biotin ligase and its proximity labeling system PhastID
CN114457048A (en) * 2022-02-11 2022-05-10 中山大学 A protein biotin ligase and its adjacent protein labeling system and application
CN114457048B (en) * 2022-02-11 2024-04-16 中山大学 Protein biotin ligase and adjacent protein marking system and application thereof
CN114606208A (en) * 2022-03-31 2022-06-10 中山大学 A high-confidence and rapid proximity protein labeling system ScPhastID and labeling method
CN114606208B (en) * 2022-03-31 2024-06-11 中山大学 Quick adjacent protein marking system SCPHASTID with high credibility and marking method
CN116162152A (en) * 2022-12-23 2023-05-26 华中科技大学同济医学院附属同济医院 Preparation method and application of biotinylated monoclonal antibody
CN118207171A (en) * 2024-05-21 2024-06-18 北京量维生物科技研究院有限公司 Biotin ligase mutant and its use in biotin production

Also Published As

Publication number Publication date
CN113481173B (en) 2022-10-14

Similar Documents

Publication Publication Date Title
CN113481173B (en) Proximal biotin ligase and application thereof
de la Torre et al. Reprogramming the genetic code
Rogawski et al. Characterizing endogenous protein complexes with biological mass spectrometry
Harbers Wheat germ systems for cell-free protein expression
Endo et al. Cell-free expression systems for eukaryotic protein production
Budisa Prolegomena to future experimental efforts on genetic code engineering by expanding its amino acid repertoire
Cui et al. Cell-free approach for non-canonical amino acids incorporation into polypeptides
US20200216825A1 (en) CAS12a MUTANT GENES AND POLYPEPTIDES ENCODED BY SAME
CN107614689A (en) Platform for incorporation of unnatural amino acids into proteins
MXPA05006836A (en) Protein arrays.
Guo et al. The development of proximity labeling technology and its applications in mammals, plants, and microorganisms
US20230062579A1 (en) Activity-specific cell enrichment
Li et al. High-throughput profiling of sequence recognition by tyrosine kinases and SH2 domains using bacterial peptide display
Shakya et al. Hyperaccurate ribosomes for improved genetic code reprogramming
CN104059891A (en) 8-hydroxyquinoline alanine translation system and application thereof
Pfeiffer et al. Proximity labeling for investigating protein-protein interactions
CA3231403A1 (en) Production method of polypeptide, tag, expression vector, evaluation method of polypeptide, production method of nucleic acid display library, and screening method
Hadd et al. Coevolution of specificity determinants in eukaryotic glutamyl-and glutaminyl-tRNA synthetases
AU2004234282A1 (en) Chaperonine-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release preparation and method of producing antibody against target protein
Kwon et al. Forced ambiguity of the leucine codons for multiple-site-specific incorporation of a noncanonical amino acid
Zhou et al. Probing the sORF-encoded peptides of Deinococcus radiodurans in response to extreme stress
Küng et al. Directed evolution of Rhodotorula gracilis d-amino acid oxidase using single-cell hydrogel encapsulation and ultrahigh-throughput screening
Stadler et al. Overexpression of recombinant proteins containing non-canonical amino acids in Vibrio natriegens: p-azido-L-phenylalanine as coupling site for 19F-tags
US20240384267A1 (en) Compositions and methods for multiplex decoding of quadruplet codons
JPWO2020080490A1 (en) Method for producing peptide library

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant